Intuitive Surgical (ISRG) has demonstrated a consistent upward trend in R&D spending since 2022, with a few fluctuations. The company's commitment to innovation is evident in the steady increase in R&D expenses, which have grown from $879 million in 2022 to $1.15 billion in 20241:
ISRG R&D Expenses, R&D Expenses YoY
Source:
1.
ISRG R&D Expense since 2022
more
less
Explore
Screener
Best looking stocks that are MACD Golden Cross
Analysis
Are KRP dividends of 0.47 per share well covered by its operating cash flow?
Learn
Step 2: Macro context and catalyst, please provide the best sources, websites, and why, in French.